Blood Podcast cover image

Pembrolizumab plus AVD for classical Hodgkin lymphoma, targeting the CD40/CD40-ligand axis in Waldenström Macroglobulinemia, and CXCR4-expressing CAR-cytokine induced killer cells in AML

Blood Podcast

00:00

Introduction

The current standard of care for the frontline treatment of classical Hodgkin lymphoma includes Doxorubicin, bleomycin, vinblastine, and decarbazine. Despite the high cure rates achieved with this approach, many patients will relapse and require intensive second-line therapies. Learn more about the effects of targeting the CD40, CD40 ligand axis in Waldenström macroglobulinemia. Review the findings from a study aimed at improving the bone marrow homing of car cytokine-induced killer cells in AML.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app